TLR4 and tuberculosis: We examined IFNγ responses to TB-antigens, CMV, Influenza and LPS (a well-known TLR4 antagonist) in order to assess the antigen-specific and non-specific immunity in TB-IRIS patients compared to non-IRIS, HIV-TB+ and HIV-TB- controls (Figure 1).